My PCR
Create Account
Logo PCR

20 May 2025

TAVI

Align for the future with the Myval Octapro transcatheter heart valve series

Sponsored by Meril

Anchorperson: A. Seth
Spokesperson: F. Mahfoud
SHOW MORE

Summary

This EuroPCR 2025 session offers a practical and evidence-based update on the Myval Octapro THV. Learn step-by-step techniques for valve-in-valve TAVI using the OctaAlign approach, and understand how intermediate sizes and precise deployment contribute to optimised hemodynamics and long-term durability.

Clinical insights are backed by key data from the Landmark RCT, including a 30-day subset analysis with a focus on women, and a one-year update from the COMPARE TAVI trial.

Real-world experience and design rationale round out this comprehensive look at a next-generation TAVI solution.

Learning Objectives

  • To learn step-by-step best practices of TAVI for valve-in-valve best procedure 
  • To understand the design and implantation technique of the novel Myval Octapro 
  • To update ourselves on the evidence and trials of the Myval THV series  
Related Content
TAVI in complex anatomy: high stakes and tight spaces TAVI outcomes in special clinical settings: cancer, diabetes, and frailty Extreme TAVI: bicuspid valves, emergency TAVI, dissections and more
Recommended for you
ESC Congress 2025: The DOUBLE-CHOICE trial Is your research ready to submit? TAVI for pure aortic regurgitation - LIVE case